Page last updated: 2024-09-04

ly 311727 and 3-(4-octadecyl)benzoylacrylic acid

ly 311727 has been researched along with 3-(4-octadecyl)benzoylacrylic acid in 1 studies

Compound Research Comparison

Studies
(ly 311727)
Trials
(ly 311727)
Recent Studies (post-2010)
(ly 311727)
Studies
(3-(4-octadecyl)benzoylacrylic acid)
Trials
(3-(4-octadecyl)benzoylacrylic acid)
Recent Studies (post-2010) (3-(4-octadecyl)benzoylacrylic acid)
3316705

Protein Interaction Comparison

ProteinTaxonomyly 311727 (IC50)3-(4-octadecyl)benzoylacrylic acid (IC50)
Phospholipase A2Homo sapiens (human)0.049

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Endo, S; Fujimoto, N; Fujita, M; Ikari, A; Ikeda, H; Ishikawa, T; Kamatari, YO; Kudo, Y; Matsunaga, T; Okada, T; Ota, A; Tanaka, Y; Toyooka, N1

Other Studies

1 other study(ies) available for ly 311727 and 3-(4-octadecyl)benzoylacrylic acid

ArticleYear
Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.
    Journal of medicinal chemistry, 2022, 03-24, Volume: 65, Issue:6

    Topics: Apoptosis; Autophagy; Autophagy-Related Proteins; Cell Line, Tumor; Cysteine Endopeptidases; Humans; Male; Prostatic Neoplasms, Castration-Resistant

2022